AU776558B2 - Tricyclic farnesyl protein transferase inhibitors - Google Patents
Tricyclic farnesyl protein transferase inhibitors Download PDFInfo
- Publication number
- AU776558B2 AU776558B2 AU20307/00A AU2030700A AU776558B2 AU 776558 B2 AU776558 B2 AU 776558B2 AU 20307/00 A AU20307/00 A AU 20307/00A AU 2030700 A AU2030700 A AU 2030700A AU 776558 B2 AU776558 B2 AU 776558B2
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- substituted
- aryl
- cycloalkyl
- arylalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electroluminescent Light Sources (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21639898A | 1998-12-18 | 1998-12-18 | |
| US09/216398 | 1998-12-18 | ||
| PCT/US1999/027939 WO2000037459A1 (en) | 1998-12-18 | 1999-12-16 | Tricyclic farnesyl protein transferase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2030700A AU2030700A (en) | 2000-07-12 |
| AU776558B2 true AU776558B2 (en) | 2004-09-16 |
Family
ID=22806914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20307/00A Ceased AU776558B2 (en) | 1998-12-18 | 1999-12-16 | Tricyclic farnesyl protein transferase inhibitors |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1140902A1 (OSRAM) |
| JP (1) | JP2002533336A (OSRAM) |
| KR (1) | KR20010081116A (OSRAM) |
| CN (1) | CN1326850C (OSRAM) |
| AR (1) | AR021718A1 (OSRAM) |
| AU (1) | AU776558B2 (OSRAM) |
| BR (1) | BR9916314A (OSRAM) |
| CA (1) | CA2354779A1 (OSRAM) |
| CO (1) | CO5160350A1 (OSRAM) |
| CZ (1) | CZ20011950A3 (OSRAM) |
| HU (1) | HUP0202152A2 (OSRAM) |
| IL (1) | IL143408A0 (OSRAM) |
| NO (1) | NO20012961L (OSRAM) |
| NZ (1) | NZ511878A (OSRAM) |
| PE (1) | PE20001342A1 (OSRAM) |
| PL (1) | PL348293A1 (OSRAM) |
| SK (1) | SK7592001A3 (OSRAM) |
| TR (1) | TR200101755T2 (OSRAM) |
| WO (1) | WO2000037459A1 (OSRAM) |
| ZA (1) | ZA200104233B (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR021718A1 (es) | 1998-12-18 | 2002-07-31 | Schering Corp | Inhibidores de transferasa de proteina farnesilo. |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| AU2002236813A1 (en) * | 2001-01-22 | 2002-07-30 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| US7585864B2 (en) | 2004-12-13 | 2009-09-08 | Schering Corporation | Farnesyl protein transferase inhibitors and their use to treat cancer |
| EP1833481A1 (en) | 2004-12-14 | 2007-09-19 | Schering Corporation | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| CA2637572A1 (en) * | 2006-01-19 | 2007-07-26 | Schering Corporation | Piperazine derivatives as farnesyl protein transferase inhibitors |
| JP6613391B2 (ja) * | 2014-03-19 | 2019-12-04 | ブイピーエス‐３，インコーポレイテッド | ２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−１−（５−置換ピリジン−２−イル）−３−（１ｈ−テトラゾール−１−イル）プロパン−２−オールおよびその調製工程 |
| CN109678791B (zh) | 2014-03-19 | 2022-07-01 | 美国陶氏益农公司 | 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| US5712280A (en) | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| US5801175A (en) * | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| PE92098A1 (es) * | 1996-07-31 | 1998-12-31 | Schering Corp | N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo |
| KR100640672B1 (ko) | 1997-06-17 | 2006-11-02 | 파마코페이아 드럭 디스커버리, 인크. | 파르네실 단백질 트랜스퍼라제의 억제에 유용한 벤즈피리도 사이클로헵탄 화합물 및 이를 포함하는 약제학적 조성물 |
| AR021718A1 (es) | 1998-12-18 | 2002-07-31 | Schering Corp | Inhibidores de transferasa de proteina farnesilo. |
-
1999
- 1999-12-16 AR ARP990106461A patent/AR021718A1/es unknown
- 1999-12-16 SK SK759-2001A patent/SK7592001A3/sk unknown
- 1999-12-16 CN CNB99816206XA patent/CN1326850C/zh not_active Expired - Fee Related
- 1999-12-16 CZ CZ20011950A patent/CZ20011950A3/cs unknown
- 1999-12-16 BR BR9916314-4A patent/BR9916314A/pt not_active IP Right Cessation
- 1999-12-16 EP EP99963980A patent/EP1140902A1/en not_active Withdrawn
- 1999-12-16 WO PCT/US1999/027939 patent/WO2000037459A1/en not_active Ceased
- 1999-12-16 PL PL99348293A patent/PL348293A1/xx not_active Application Discontinuation
- 1999-12-16 TR TR2001/01755T patent/TR200101755T2/xx unknown
- 1999-12-16 JP JP2000589531A patent/JP2002533336A/ja active Pending
- 1999-12-16 CA CA002354779A patent/CA2354779A1/en not_active Abandoned
- 1999-12-16 HU HU0202152A patent/HUP0202152A2/hu unknown
- 1999-12-16 IL IL14340899A patent/IL143408A0/xx unknown
- 1999-12-16 AU AU20307/00A patent/AU776558B2/en not_active Ceased
- 1999-12-16 CO CO99078843A patent/CO5160350A1/es unknown
- 1999-12-16 NZ NZ511878A patent/NZ511878A/en unknown
- 1999-12-16 KR KR1020017007632A patent/KR20010081116A/ko not_active Abandoned
- 1999-12-17 PE PE1999001295A patent/PE20001342A1/es not_active Application Discontinuation
-
2001
- 2001-05-23 ZA ZA200104233A patent/ZA200104233B/en unknown
- 2001-06-15 NO NO20012961A patent/NO20012961L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5160350A1 (es) | 2002-05-30 |
| CA2354779A1 (en) | 2000-06-29 |
| TR200101755T2 (tr) | 2001-09-21 |
| BR9916314A (pt) | 2001-10-02 |
| HUP0202152A2 (en) | 2002-10-28 |
| NO20012961D0 (no) | 2001-06-15 |
| PE20001342A1 (es) | 2000-12-09 |
| CN1326850C (zh) | 2007-07-18 |
| AU2030700A (en) | 2000-07-12 |
| EP1140902A1 (en) | 2001-10-10 |
| JP2002533336A (ja) | 2002-10-08 |
| CZ20011950A3 (cs) | 2001-12-12 |
| IL143408A0 (en) | 2002-04-21 |
| NO20012961L (no) | 2001-08-16 |
| PL348293A1 (en) | 2002-05-20 |
| WO2000037459A1 (en) | 2000-06-29 |
| NZ511878A (en) | 2003-10-31 |
| KR20010081116A (ko) | 2001-08-27 |
| ZA200104233B (en) | 2002-08-22 |
| SK7592001A3 (en) | 2002-03-05 |
| AR021718A1 (es) | 2002-07-31 |
| CN1334811A (zh) | 2002-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6372747B1 (en) | Farnesyl protein transferase inhibitors | |
| JP3368905B2 (ja) | Ｇ−タンパク質機能の阻害および増殖性疾患の処置に有用な三環式アミドおよび三環式尿素化合物 | |
| US5891872A (en) | Tricyclic compounds | |
| JP2999556B2 (ja) | ファルネシルタンパク質トランスフェラーゼの阻害に有用な三環式化合物 | |
| KR100936854B1 (ko) | 옥시토신 길항제로서의 치환된 트리아졸 유도체 | |
| KR20010081115A (ko) | 파르네실 단백질 트랜스퍼라제 억제제 | |
| AU753658B2 (en) | Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase | |
| KR20040098004A (ko) | 항종양제로서의 파르네실 단백질 트랜스퍼라제 억제제 | |
| HUP0000191A2 (hu) | Farnezil-protein-transzferáz inhibitorként alkalmazható új triciklusos piperidinil-vegyületek | |
| CN1326850C (zh) | 三环类法尼基蛋白转移酶抑制剂 | |
| CZ87499A3 (cs) | Substituované deriváty benzocykloheptapyridinu použitelné při léčbě nádorových onemocnění tím, že inhibují farnesylprotein transferázu | |
| MXPA01006241A (en) | Tricyclic farnesyl protein transferase inhibitors | |
| KR20010013825A (ko) | 파네실 단백질 전이효소를 억제하기에 유용한비스피리도-사이클로헵탄 화합물 | |
| MXPA99012059A (en) | Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase | |
| SK33299A3 (en) | Tricyclic compounds useful for inhibition of farnesyl protein transferase | |
| MXPA97007232A (en) | Triciaclic compounds of amida and urea, useful for inhibition of the function of protein g and for the treatment of proliferati diseases | |
| CZ84499A3 (cs) | Substituované deriváty benzocykloheptapyridinu použitelné pro inhibici farnesylprotein transferasy |